Abstract
Irritable bowel syndrome (IBS) is globally one of the most prevalent gastrointestinal disorders with a negative impact on quality of life and socio-economic status of patients. Recently, controversial evidences suggest that Blastocystis sp. and Dientamoeba fragilis infections may be implicated in the development of IBS. We performed a systematic review and meta-analysis to examine the possible association regarding this issue. PubMed, ScienceDirect, Scopus, Web of Science, and Cochrane electronic databases were searched (up to February 2017) to identify the relevant studies. Pooled odds ratio (OR) and 95% confidence intervals were estimated using a random effects meta-analysis model on data from included studies. A total of 17 studies including 5882 participants (2527 patients and 3310 controls) met the eligibility criteria. Individuals with Blastocystis infection were found to have a positive association with IBS (OR, 2.19; 95% CI, 1.54–3.13), while this association was not observed for D. fragilis infection (OR, 1.13; 95% CI, 0.22–5.72). In subgroup analysis for Blastocystis infection, the pooled ORs were OR 2.29, 95% CI 1.55–3.41; OR 1.70, 95% CI 0.83–3.44; and OR 3.83, 95% CI 2.34–6.27 for hospital-based, healthy volunteers, and combined controls, respectively. Considering the subtypes, meta-analysis result demonstrated significant positive ORs for ST1 (OR, 4.40; 95% CI, 2.81–6.90) and ST3 (OR, 1.94; 95% CI, 1.36–2.77) to be potential risk factors for IBS. Our results support the existence of a positive association between Blastocystis sp. and IBS. Further studies with more sample size should be performed to better investigate the real impact of these parasites on the occurrence of IBS.
Similar content being viewed by others
Change history
18 July 2017
An erratum to this article has been published.
References
Ajjampur SS, Tan KS (2016) Pathogenic mechanisms in Blastocystis spp.—interpreting results from in vitro and in vivo studies. Parasitol Int 65:772–779
Alfellani MA, Stensvold CR, Vidal-Lapiedra A, Onuoha ESU, Fagbenro-Beyioku AF, Clark CG (2013a) Variable geographic distribution of Blastocystis subtypes and its potential implications. Acta Trop 126:11–18
Alfellani MA, Taner-Mulla D, Jacob AS, Imeede CA, Yoshikawa H, Stensvold CR, Clark CG (2013b) Genetic diversity of Blastocystis in livestock and zoo animals. Protist 164:497–509
Barratt JL, Harkness J, Marriott D, Ellis JT, Stark D (2011) A review of Dientamoeba fragilis carriage in humans: several reasons why this organism should be considered in the diagnosis of gastrointestinal illness. Gut Microbe 2:3–12
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
Borody T, Warren E, Wettstein A, Robertson G, Recabarren P, Fontella A, Herdnman K, Surace R (2002) Eradication of Dientamoeba fragilis can resolve IBS-like symptoms. J Gastroenterol Hepatol 17:103
Brair SL, Eltayeb LB, Elgazy SA, Nail AM, Aljafari AS (2016) Frequency of intestinal parasites among Sudanese patients with irritable bowel syndrome. Am J Health Res 4:82–85
Canavan C, West J, Card T (2014) Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 40:1023–1034
Cann P, Read N, Brown C, Hobson N, Holdsworth C (1983) Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 24:405–411
Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y (2012) Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 24:521–530
Cekin AH, Cekin Y, Adakan Y, Tasdemir E, Koclar FG, Yolcular BO (2012) Blastocystosis in patients with gastrointestinal symptoms: a case–control study. BMC Gastroenterol 12:122
Das R, Khalil S, Mirdha B, Makharia GK, Dattagupta S, Chaudhry R (2016) Molecular characterization and subtyping of Blastocystis species in irritable bowel syndrome patients from North India. PLoS One 11:e0147055
Denoeud F, Roussel M, Noel B, Wawrzyniak I, Da Silva C, Diogon M, Viscogliosi E, Brochier-Armanet C, Couloux A, Poulain J (2011) Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite. Genome Biol 12:29
Dogruman-Al F, Simsek Z, Boorom K, Ekici E, Sahin M, Tuncer C, Kustimur S, Altinbas A (2010) Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD patients in Ankara, Turkey. PLoS One 5:e15484
Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
El Safadi D, Gaayeb L, Meloni D, Cian A, Poirier P, Wawrzyniak I, Delbac F, Dabboussi F, Delhaes L, Seck M (2014) Children of senegal river basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis 14:164
Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P (2012) Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome. Am J Trop Med Hyg 87:1046–1052
Fallahi S, Rostami A, Mohammadid M, Ebrahimzadeh F, Pournia Y (2016) Practical parasitology courses and infection with intestinal parasites in students. J Infect Public Health 9:654–660
Ford AC, Spiegel BM, Talley NJ, Moayyedi P (2009) Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 7:1279–1286
Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G (1999) Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 18:436–439
Higgins JP, Green S (2011) Cochrane handbook for systematic reviews of interventions. Wiley, Chichester
Jimenez-Gonzalez DE, Martinez-Flores WA, Reyes-Gordillo J, Ramirez-Miranda ME, Arroyo-Escalante S, Romero-Valdovinos M, Stark D, Souza-Saldivar V, Martinez-Hernandez F, Flisser A (2012) Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res 110:1269–1275
Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133:24–33
Khademvatan S, Masjedizadeh R, Rahim F, Mahbodfar H, Salehi R, Yousefi-razin E, Foroutan M (2017) Blastocystis and irritable bowel syndrome: frequency and subtypes from Iranian patients. Parasitol Int 66:142–145
Kiani H, Haghighi A, Rostami A, Azargashb E, Tabaei SJS, Solgi A, Zebardast N (2016) Prevalence, risk factors and symptoms associated to intestinal parasite infections among patients with gastrointestinal disorders in Nahavand, western Iran. Rev Inst Med Trop Sao Paulo 58:42
Krogsgaard LR, Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P (2015) The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study. Clin Gastroenterol Hepatol 13:507–513
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130:1480–1491
Lovell RM, Ford AC (2012) Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 10:712–721
Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100:373–382
Mirza H, Wu Z, Teo JD, Tan KS (2012) Statin pleiotropy prevents rho kinase-mediated intestinal epithelial barrier compromise induced by Blastocystis cysteine proteases. Cellular Microbiol 14:1474–1484
Morgan DR, Benshoff M, Cáceres M, Becker-Dreps S, Cortes L, Martin CF, Schmulson M, Peña R (2012) Irritable bowel syndrome and gastrointestinal parasite infection in a developing nation environment. Gastroenterol Res Pract 2012:343812
Mumcuoğlu İ, Coşkun FA, Aksu N, Pürnak T, Güngör Ç (2013) Role of Dientamoeba fragilis and Blastocystis spp. in irritable bowel syndrome. Turkiye Parazitol Derg 37:73–77
Nourrisson C, Scanzi J, Pereira B, NkoudMongo C, Wawrzyniak I, Cian A, Viscogliosi E, Livrelli V, Delbac F, Dapoigny M (2014) Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS One 9:e111868
Omrani VF, Fallahi S, Rostami A, Siyadatpanah A, Barzgarpour G, Mehravar S, Memari F, Hajialiani F, Joneidi Z (2015) Prevalence of intestinal parasite infections and associated clinical symptoms among patients with end-stage renal disease undergoing hemodialysis. Infection 43:537–544
Park SR, Han AR, Ban Y-H, Yoo YJ, Kim EJ, Yoon YJ (2010) Genetic engineering of macrolide biosynthesis: past advances, current state, and future prospects. Appl Microbiol Biotechnol 85:1227–1239
Poirier P, Wawrzyniak I, Vivarès CP, Delbac F, El Alaoui H (2012) New insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Pathog 8:e1002545
Puthia MK, Sio SW, Lu J, Tan KS (2006) Blastocystis ratti induces contact-independent apoptosis, F-actin rearrangement, and barrier function disruption in IEC-6 cells. Infect Immun 74:4114–4123
Puthia MK, Lu J, Tan KS (2008) Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-κB-dependent manner. Eukaryot Cell 7:435–443
Ragavan ND, Kumar S, Chye TT, Mahadeva S, Shiaw-Hooi H (2015) Blastocystis sp. in irritable bowel syndrome (ibs)-detection in stool aspirates during colonoscopy. PLoS One 10:e0121173
Rajilic-Stojanovic M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S, de Vos WM (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141:1792–1801
Ramírez JD, Sánchez LV, Bautista DC, Corredor AF, Flórez AC, Stensvold CR (2014) Blastocystis subtypes detected in humans and animals from Colombia. Infect Genetic Evol 22:223–228
Ramirez-Miranda ME, Hernandez-Castellanos R, Lopez-Escamilla E, Moncada D, Rodriguez-Magallan A, Pagaza-Melero C, Gonzalez-Angulo A, Flisser A, Kawa-Karasik S, Maravilla P (2010) Parasites in Mexican patients with irritable bowel syndrome: a case-control study. Parasite Vector 3:96
Saito YA, Schoenfeld P, Locke GR III (2002) The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 97:1910–1915
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349:g7647
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605
Stanghellini V, Tosetti C, Barbara G, De Giorgio R, Cogliandro L, Cogliandro R, Corinaldesi R (2002) Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol 97:2738–2743
Stark D, Barratt J, Chan D, Ellis JT (2016) Dientamoeba fragilis, the neglected trichomonad of the human bowel. Clin Microbiol Rev 29:553–580
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283:2008–2012
Surangsrirat S, Thamrongwittawatpong L, Piyaniran W, Naaglor T, Khoprasert C, Taamasri P, Mungthin M, Leelayoova S (2010) Assessment of the association between Blastocystis infection and irritable bowel syndrome. J Med Assoc Thail 93:119–124
Tan KS (2008) New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 21:639–665
Thompson JR (2016) Is irritable bowel syndrome an infectious disease? World J Gastroenterol 22:1331
Tillisch K, Mayer EA, Labus JS (2011) Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology 140:91–100
Tungtrongchitr A, Manatsathit S, Kositchaiwat C, Ongrotchanakun J, Munkong N, Chinabutr P, Leelakusolvong S, Chaicumpa W (2004) Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health 35:705–710
Vasquez-Rios G, Machicado JD, Gamero MT, Pezua A, Betancourt AB, Terashima A, Marcos LA (2015) Evaluating the role of intestinal parasites in the high rates of irritable bowel syndrome in South America: a pilot study. Folia Parasitol 62:065
Wang L, Fang X, Pan G (2004) Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 53:1096–1101
Wells GA SB, O’Connell D, Peterson J, Welch V, Losos M (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
Yakoob J, Jafri W, Jafri N, Khan R, Islam M, Beg MA, Zaman V (2004) Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg 70:383–385
Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R (2010a) Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 107:679–684
Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R (2010b) Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis. Parasitol Res 106:1033–1038
Yan Y, Su S, Lai R, Liao H, Ye J, Li X, Luo X, Chen G (2006) Genetic variability of Blastocystis hominis isolates in China. Parasitol Res 99:597–601
Acknowledgements
The authors would like to thank Dr. Hamed Behniafar for his assistance during the preparation of this manuscript. This work was supported by the Shahid Beheshti University of Medical Science, Tehran, Iran under grant number 13/1403-6443.
Author information
Authors and Affiliations
Contributions
A.R., S.M.R., A.H., B.A., and S.J.S. conceived the study. A.R. B.A. and S.J.S. collected all data. A.R., S.M.R., and V.S. analyzed and interpreted the data. A.R. and A.H. drafted the manuscript. All authors commented on the drafts of the manuscript and approved the final copy of the paper.
Corresponding author
Ethics declarations
Conflict interest
The authors declare that there is no conflict of interests regarding the publication of this paper.
Ethical approval
This study received the approval from the Shahid Beheshti University of Medical Science Ethical Committee.
Informed consent
There is no informed consent for this review article
Additional information
An erratum to this article is available at https://doi.org/10.1007/s00436-017-5556-1.
Rights and permissions
About this article
Cite this article
Rostami, A., Riahi, S.M., Haghighi, A. et al. The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis. Parasitol Res 116, 2361–2371 (2017). https://doi.org/10.1007/s00436-017-5535-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-017-5535-6